Grade is not a significant factor in determining recurrence; however, grade is highly significant in predicting progression (≥T2). 12 , 13 Irrespective of the grading system used, both WHO 2004/2022 and WHO 1973 show differences in progression within the carcinoma categories, with LG progressing less than HG (WHO 2004/2022), while progression rates in G3>G2>G1 using WHO 1973.
← all excerpts
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study.
1
—
—